The subtle nuances of intranasal corticosteroids [PDF]
Journal of Otolaryngology - Head and Neck Surgery, 2021 Background In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training,
James Fowler +2 more
doaj +6 more sources
Medical adherence to intranasal corticosteroids in adult patients [PDF]
Brazilian Journal of Otorhinolaryngology, 2017 Introduction: The adherence to medical treatment in allergic rhinitis is poorly evaluated in clinical practice. Objectives: To evaluate adherence to intranasal corticosteroids in the treatment of allergic rhinitis patients.
Emre Ocak, Baran Acar, Deniz Kocaöz
doaj +5 more sources
Using intranasal corticosteroids. [PDF]
CMAJ, 2021 About 5% of Canadians are affected by sinonasal inflammation.[1][1] There is broad expert consensus supporting the effectiveness of intranasal corticosteroids for treating allergic and nonallergic rhinitis, acute rhinosinusitis and chronic rhinosinusitis with and without nasal polyposis.[2][2],[3 ...
Fowler J, Sowerby LJ.
europepmc +4 more sources
Intranasal Corticosteroids and Oral Montelukast for Paediatric Obstructive Sleep Apnoea: A Systematic Review [PDF]
PharmaceuticsBackground/Objectives: Paediatric Obstructive Sleep Apnoea (OSA) is characterised by recurrent episodes of upper airway obstruction during sleep, manifesting as snoring, intermittent oxygen desaturation, and frequent nocturnal awakenings.
Marco Zaffanello +5 more
doaj +2 more sources
Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis [PDF]
Clinical Ophthalmology, 2022 Anastasiya Vinokurtseva,1 Matthew Fung,1 Erica Ai Li,2 Richard Zhang,1 James J Armstrong,1,2 Cindy ML Hutnik1– 3 1Department of Ophthalmology, Schulich School of Medicine and Dentistry, London, Ontario, Canada; 2Department of Pathology, Schulich School ...
Vinokurtseva A +5 more
doaj +2 more sources
Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index [PDF]
Journal of Asthma and Allergy, 2021 Peter T Daley-Yates,1 Désirée Larenas-Linnemann,2 Chaitanya Bhargave,3 Manish Verma3 1Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline plc., Research and Development, Uxbridge, UK; 2Center of Excellence in Asthma and Allergy, Médica Sur ...
Daley-Yates PT +3 more
doaj +2 more sources
Intranasal corticosteroids: patient administration angles and impact of education [PDF]
Rhinology Online, 2020 Introduction: Intranasal corticosteroids sprays (INCS) are first line treatment for allergic rhinitis and are frequently used for chronic rhinosinusitis.
Sara Treat +8 more
doaj +2 more sources
Intranasal corticosteroids for non-allergic rhinitis. [PDF]
Cochrane Database Syst Rev, 2019 Non-allergic rhinitis is defined as dysfunction and non-infectious inflammation of the nasal mucosa that is caused by provoking agents other than allergens or microbes. It is common, with an estimated prevalence of around 10% to 20%. Patients experience symptoms of nasal obstruction, anterior rhinorrhoea/post-nasal drip and sneezing.
Segboer C +8 more
europepmc +4 more sources
The Awareness of the Jordanian Population Regarding Intranasal Corticosteroids' Uses for Allergic Rhinitis [PDF]
International Archives of OtorhinolaryngologyHasan Ibrahim Al-Balas +7 more
doaj +2 more sources
High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy [PDF]
Laryngoscope Investigative OtolaryngologyObjective This study aimed to evaluate the clinical remission rate and changes in medication use in patients with eosinophilic chronic rhinosinusitis (ECRS) treated with dupilumab for > 2 years.
Seiichiro Kamimura +4 more
doaj +2 more sources